Analyst Says Buy This Pharma Stock Before Earnings

Sarepta Therapeutics earnings are due next Thursday

Nov 1, 2019 at 12:06 PM
facebook X logo linkedin


Sarepta Therapeutics Inc (NASDAQ:SRPT) stock is up 4.3% today to trade at $86.63, after Guggenheim initiated coverage with a "buy" rating and a $183 price target -- a 120% premium to last night's close. This bull note comes ahead of the Duchenne muscular dystrophy (DMD) specialist's turn in the earnings confessional, slated for after the market closes next Thursday, Nov. 7.

Most analysts are already upbeat toward SRPT stock. Prior to today, 14 brokerages maintained a "buy" or better rating on the equity, compared to one "hold," and not a single "sell." Plus, the average 12-month price target of $187.86 represents expected upside of 116.9% to current trading levels.

Skepticism has been ramping up in other corners of the Street, though. Short interest on SRPT surged 7.6% in the most recent reporting period to 15.59 million shares -- the most since July 2016. These bearish bets represent 22% of Sarepta Therapeutics stock's available float, or 9.2 times the average daily pace of trading.

Historically speaking, SRPT stock tends to do well after earnings, having closed higher the day after five of the drugmaker's past eight quarterly events. SRPT has averaged a next-day move of 6.6% over the last two years, regardless of direction, with the options market pricing in a slimmer 6.2% swing for Friday's trading.

Looking at the charts, Sarepta Therapeutics stock has struggled in the second half of 2019, down nearly 46% from its July 15 annual high of $158.80 -- due in part to a late-August bear gap sparked by the Food and Drug Administration's (FDA) failure to approve the company's DMD injection treatment. More recently, the equity has recovered from its Sept. 26 52-week low at $72.05, but is struggling to break out above its 50-day moving average.

srpt stock daily price chart on nov 1

 

 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI